tiprankstipranks
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Australian Market
Holding AU:NOX?
Track your performance easily

Noxopharm Ltd. (NOX) Financial Statements

2 Followers

Noxopharm Ltd. Financial Overview

Noxopharm Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.012; its P/E ratio is -8.61; Noxopharm Ltd. is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 14.01MAU$ 26.80MAU$ 7.10MAU$ 2.91MAU$ 12.61M
Total AssetsAU$ 26.59MAU$ 47.85MAU$ 20.07MAU$ 4.30MAU$ 14.55M
Total DebtAU$ 160.62KAU$ 349.31KAU$ 5.00MAU$ 3.93MAU$ 3.28M
Net DebtAU$ -13.85MAU$ -26.45MAU$ -2.10MAU$ 1.02MAU$ -9.33M
Total LiabilitiesAU$ 2.48MAU$ 7.08MAU$ 7.19MAU$ 5.75MAU$ 4.40M
Stockholders EquityAU$ 24.12MAU$ 40.78MAU$ 12.87MAU$ -100.67KAU$ 10.15M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Noxopharm Ltd. Earnings and Revenue History

Noxopharm Ltd. Debt to Assets

Noxopharm Ltd. Cash Flow

Noxopharm Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis